
CIT AWARE: Evolving Paradigms in Cancer Immunotherapy:
Use of Biomarkers and Combination Therapy Targeting the PD-1/PD-L1 Pathway
These case-based enduring activities will cover the treatment and management of patients with advanced solid tumors who are treated or eligible for treatment with immunotherapy. These activities are designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professional involved in the management of patients with advanced solid tumors who are treated or eligible for treatment with immunotherapy.
VIRTUAL SUMMITS
Open for English Version
Open for Spanish Version
Open for French Version
Open for German Version
VIRTUAL PATHWAYS
Open for English Version
Open for Spanish Version
Open for French Version
Open for German Version
